BCM
BIOS Capital Management Portfolio holdings
AUM
$72.6M
This Quarter Return
-15.06%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$79.2M
AUM Growth
+$79.2M
(-16%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACTU
1
Actuate Therapeutics, Inc. Common stock
ACTU
$180M
| $67M | 84.59% |
9,893,651
| – | – |
|
2
Lantern Pharma
LTRN
$43.5M
| $4.28M | 5.4% |
1,207,709
| – | – |
|
|
RNTX
3
Rein Therapeutics, Inc. Common Stock
RNTX
$31.1M
| $2.99M | 3.78% |
1,690,751
| – | – |
|
4
Cognition Therapeutics
CGTX
$179M
| $2.52M | 3.19% |
6,000,000
| – | – |
|
5
IN8bio
INAB
$10M
| $1.43M | 1.8% |
8,600,001
| – | – |
|
|
IRD
6
Opus Genetics, Inc. Common Stock
IRD
$73.7M
| $977K | 1.23% |
995,249
| – | – |
|